Page 4 - பிராங்கோயிஸ் பிலிப் ஷாம்பெயின் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

  OTTAWA The federal government is committing almost $200 million to boost the manufacturing capacity at a Mississauga, Ont.-based plant in order to fulfill future vaccine and therapeutics needs. Federal innovation minister Francois-Philippe Champagne spoke to the announcement on Tuesday, stating that Resilience Biotechnologies will receive $199.16 million, which will go to “modernize and expand” the company’s facilities – a project with a total price tag of $401.51 million. “Once completed, the new facility is expected to be able to manufacture between 112 million and 640 million doses of mRNA vaccines per year – a significant boost to our domestic capacity. This will position Canada well to attract vaccine manufacturing for both the Canadian market and the export market,” said Champagne.

Anita anandJustin trudeauStrategic innovation fundFrancois philippe champagneResilience biotechnologiesVancouver based providence therapeuticsMinister justin trudeauProcurement minister anita anandஅனிதா ஆனந்த்ஜஸ்டின் திருடேௌஉமூலோபாய கண்டுபிடிப்பு நிதிபிராங்கோயிஸ் பிலிப் ஷாம்பெயின்அமைச்சர் ஜஸ்டின் திருடேௌஉப்ரொக்யூர்மெஂட் அமைச்சர் அனிதா ஆனந்த்